These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 30597449

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Lysosome-targeted chemotherapeutics: Anticancer mechanism of N-heterocyclic carbene iridium(III) complex.
    Zhang J, Liu J, Liu X, Liu B, Song S, He X, Che C, Si M, Yang G, Liu Z.
    J Inorg Biochem; 2020 Jun; 207():111063. PubMed ID: 32222581
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Imidazole and Benzimidazole Modified Half-Sandwich IridiumIII N-Heterocyclic Carbene Complexes: Synthesis, Anticancer Application, and Organelle Targeting.
    Liu X, Han Y, Ge X, Liu Z.
    Front Chem; 2020 Jun; 8():182. PubMed ID: 32257999
    [Abstract] [Full Text] [Related]

  • 11. Structure-activity relationships for highly potent half-sandwich organoiridium(III) anticancer complexes with C^N-chelated ligands.
    Yang Y, Guo L, Ge X, Shi S, Gong Y, Xu Z, Zheng X, Liu Z.
    J Inorg Biochem; 2019 Feb; 191():1-7. PubMed ID: 30445339
    [Abstract] [Full Text] [Related]

  • 12. Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents.
    Li J, Tian Z, Xu Z, Zhang S, Feng Y, Zhang L, Liu Z.
    Dalton Trans; 2018 Nov 13; 47(44):15772-15782. PubMed ID: 30357192
    [Abstract] [Full Text] [Related]

  • 13. Ferrocene-Appended Iridium(III) Complexes: Configuration Regulation, Anticancer Application, and Mechanism Research.
    Ge X, Chen S, Liu X, Wang Q, Gao L, Zhao C, Zhang L, Shao M, Yuan XA, Tian L, Liu Z.
    Inorg Chem; 2019 Oct 21; 58(20):14175-14184. PubMed ID: 31559820
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. DFT Investigation of the Mechanism of Action of Organoiridium(III) Complexes As Anticancer Agents.
    Ritacco I, Russo N, Sicilia E.
    Inorg Chem; 2015 Nov 16; 54(22):10801-10. PubMed ID: 26492153
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Novel half-sandwich iridium OˆC (carbene)-Complexes: In vitro and in vivo tumor growth suppression and pro-apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes.
    Xu Z, Zhang Y, Zhang S, Jia X, Zhong G, Yang Y, Du Q, Li J, Liu Z.
    Cancer Lett; 2019 Apr 10; 447():75-85. PubMed ID: 30673591
    [Abstract] [Full Text] [Related]

  • 20. Preparation and the anticancer mechanism of configuration-controlled Fe(II)-Ir(III) heteronuclear metal complexes.
    Shao M, Liu X, Sun Y, Dou S, Chen Q, Yuan XA, Tian L, Liu Z.
    Dalton Trans; 2020 Sep 22; 49(36):12599-12609. PubMed ID: 32857087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.